Stockreport

NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

Neuropace, Inc.  (NPCE) 
PDF MOUNTAIN VIEW, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of [Read more]